MedPath

Health Canada Approvals

Health Canada approved pharmaceutical products and drug approvals in Canada

Health Canada
Canada
49,245 Approvals
Showing 45941 to 45960 of 49,245 approvalsPage 2298 of 2463

PHYTONADIONE INJ 2MG/ML

Approved: Dec 31, 1971
International Medication Systems Ltd.

SODIUM BICARBONATE INJ 7.5%

Approved: Dec 31, 1971
International Medication Systems Ltd.

LIDOCAINE HCL JELLY 2%

Approved: Dec 31, 1971
International Medication Systems Ltd.

COLPRONE TAB 5MG

Approved: Dec 31, 1969
ayerst laboratories

ATROMID S CAP 500MG

Approved: Dec 31, 1968
ayerst laboratories

PROTOPAM CHLORIDE INJ 1GM

Approved: Dec 31, 1966
ayerst laboratories

ORNADE LIQUID

Approved: Dec 31, 1965
smithkline beecham consumer healthcare, division of smithkline beecham inc.

ORNADE DM 15 LIQ

Approved: Dec 31, 1965
smithkline beecham consumer healthcare, division of smithkline beecham inc.

MYSOLINE TAB 250MG

Approved: Dec 31, 1965
ayerst laboratories

DERMOPLAST AEROSOL SPRAY

Approved: Dec 31, 1961
ayerst laboratories

PENICILLIN G POTASSIUM INJ 5000000IU

Approved: Dec 31, 1951
ayerst laboratories

PREMARIN TABLETS 2.5MG

Approved: Dec 31, 1951
ayerst laboratories

COPPERTONE SKIN SELECTS FOR OILY SKIN-SPF15

Approved: Dec 31, 1996
schering-plough healthcare products canada, a division of schering canada inc.

COPPERTONE SKIN SELECTS FOR SENS.SKIN SPF15

Approved: Dec 31, 1996
schering-plough healthcare products canada, a division of schering canada inc.

COPPERTONE SKIN SELECTS FOR DRY SKIN -SPF15

Approved: Dec 31, 1996
schering-plough healthcare products canada, a division of schering canada inc.

ARRID XX BABY FRESH SOLID - STK 25%

Approved: Dec 31, 1996
carter products, division of carter wallace ns inc.

ARRID XX UNSCENTED SOLID - STK 25%

Approved: Dec 31, 1996
carter products, division of carter wallace ns inc.

ARRID XX GLIDE-ON CITRUS SPLASH-GEL TOP 22%

Approved: Dec 31, 1996
carter products, division of carter wallace ns inc.

ARRID FOR MEN GLIDE-ON WILD BREEZE

Approved: Nov 12, 1996
carter products, division of carter wallace ns inc.

DOXORUBICIN HCL FOR INJ. U.S.P. 50MG/VIAL

Approved: Dec 31, 1995
david bull laboratories (pty) ltd.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.